CAS 16616-39-0

Fórmula: C15H9NO3

InChI: InChI=1S/C15H9NO3/c17-15(10-9-12-5-2-1-3-6-12)13-7-4-8-14(11-13)16(18)19/h1-8,11H

Chave InChI: JODIUOIVYGKAJH-UHFFFAOYSA-N

SMILES: C1=CC=C(C=C1)C#CC(=O)C2=CC(=CC=C2)[N+](=O)[O-]

MLS000532223

CAS: 16616-39-0

MLS000532223

Fórmula: C₁₅H₉NO₃

Pureza: ≥98%

Peso molecular: 251.24

Ref: 54-BUP04237

1-(3-Nitrophenyl)-3-phenyl-2-propyn-1-one

CAS: 16616-39-0

Fórmula: C₁₅H₉NO₃

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 251.2369

Ref: IN-DA001WIU

MLS000532223

CAS: 16616-39-0

MLS000532223 is a selectiveRho family GTPases inhibitor(EC50 : 16 μM to 120 μM).

Fórmula: C₁₅H₉NO₃

Pureza: 98.6%

Cor e Forma: Solid

Peso molecular: 251.2369

Ref: TM-T8473

2-Propyn-1-one, 1-(3-nitrophenyl)-3-phenyl-

CAS: 16616-39-0

Pureza: 98%

Peso molecular: 251.2409973

Ref: 10-F862003

MLS000532223

CAS: 16616-39-0

MLS000532223 is a small molecule that is potent and selective against a variety of cancer cell lines. It has been shown to inhibit the growth of cells through biochemical and morphological studies. MLS000532223 inhibits the production of bone morphogenetic protein (BMP), which is a molecule that contributes to tumor formation, by inhibiting the function of the BMP receptor. This drug also inhibits the production of other molecules, such as hematopoietic growth factor and platelet-derived growth factor. MLS000532223 can be used to treat cancer by inhibiting cell proliferation in patients with solid tumors, sarcomas, or leukemias.

Fórmula: C₁₅H₉NO₃

Pureza: Min. 95%

Peso molecular: 251.24 g/mol

Ref: 3D-RAA61639